Gleacher & Company Further Expands Equity Healthcare Team
NEW YORK--([ BUSINESS WIRE ])--Gleacher & Company Securities, Inc., a broker-dealer subsidiary of Gleacher & Company, Inc. (Nasdaq: GLCH), today announced another addition to its Healthcare Research team with the hiring of Sung Ji Nam.
"Developing our equity platform is a critical element in our overall growth initiative and adding highly regarded research analysts like Sung Ji is crucial to our success. We see exceptional opportunities in Healthcare and we are very pleased to welcome Sung Ji to our Research Department."
Ms. Nam joins Gleacher & Company from JP Morgan where she worked for the last four years on a team that covered 25 names in the Life Science Tools, Contract Research Organizations, Diagnostics, and Medical Devices spaces. At Gleacher & Company, she will be focused on Life Science Tools companies which will complement the firma™s existing Medical Devices and Diagnostics practice headed by Amit Hazan.
Ms. Nam is a graduate of the Harvard Business School. Prior to attending business school, she worked as an investment banking associate at Robertson Stephens. Ms. Nam received her BA in Chemistry, magna cum laude, from Harvard College.
Robert Meier, Head of Gleacher & Companya™s Equity division, said, aWe continue to believe thatestablishing arespected Healthcare research platform in addition to our already strong Technology, Industrial, and REIT franchiseswill position us very well to continue to serve our key clients. Sung Ji is a fabulous addition to the team.a
Eric Gleacher, Chief Executive Officer of Gleacher & Company, said, aDeveloping our equity platform is a critical element in our overall growth initiative and adding highly regarded research analysts like Sung Ji is crucial to our success. We see exceptional opportunities in Healthcare and we are very pleased to welcome Sung Ji to our Research Department.a
About Gleacher & Company
Gleacher & Company, Inc. (Nasdaq: GLCH), is an independent, full service investment bank that provides corporate and institutional clients with strategic, research-based investment opportunities, capital raising, and financial advisory services, including merger and acquisition, restructuring, recapitalization, and strategic alternative analysis, as well as securities brokerage services. For more information, please visit [ www.gleacher.com ].
Forward Looking Statements
This press release contains aforward-looking statements.a These statements are not historical facts but instead represent the Companya™s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Companya™s control. The Companya™s forward-looking statements are subject to various risks and uncertainties, including the conditions of the securities markets, generally, and acceptance of the Companya™s services within those markets and other risks and factors identified from time to time in the Companya™s filings with the Securities and Exchange Commission. It is possible that the Companya™s actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in its forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements. The Company does not undertake to update any of its forward-looking statements.